Q32 Bio
QTTB • NASDAQ
Q32 Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jodie Pope Morrison, with a market cap of $106.1M.
CEOJodie Pope Morrison
Next Earnings
Upcoming earnings announcement for Q32 Bio
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.62
Earnings History
Past 8 earnings reports for Q32 Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | $3.65Est: -$0.85 | +529.4% | $53.7M | — |  10-K |
| Nov 13, 2025 | Q3 2025 | -$0.60Est: -$1.27 | +52.8% | - | — | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.78Est: -$1.14 | +31.6% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.90 | — | - | — | 10-Q |
| Mar 11, 2025 | Q4 2024 | -$1.16 | — | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$1.46Est: -$1.40 | -4.3% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$1.42Est: -$1.04 | -36.5% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$6.33Est: -$2.32 | -172.8% | -Est: $170.0K | -100.0% | 10-Q |